Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Knoxville, Tennessee
- Most recent report
- 10-Q, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 1,001+ filings
- On EDGAR
- CIK 315545
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 79
News 8 of 281
- 8-K Leadership change Jul 1, 2026
- 8-K Shareholder vote results Jun 22, 2026
- 8-K Current report on a material event Jun 18, 2026
- 8-K Other events Apr 21, 2026
- 8-K Current report on a material event Feb 2, 2026
- 8-K Shareholder vote results Jun 20, 2025
- 8-K Current report on a material event Jun 18, 2025
- 8-K Current report on a material event Apr 16, 2025
Prospectuses and Registrations 8 of 54
- 25-NSE Notice that a security was delisted Apr 21, 2017
- 25-NSE Notice that a security was delisted Apr 21, 2017
- 424B3 Prospectus supplement for an offering Mar 6, 2017
- 424B3 Prospectus supplement for an offering Feb 21, 2017
- 424B3 Prospectus supplement for an offering Feb 9, 2017
- 424B4 Final prospectus for an offering Jan 31, 2017
- S-1/A Registration statement for an offering, amended Jan 26, 2017
- S-1/A Registration statement for an offering, amended Jan 19, 2017
Proxies 8 of 59
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- PRE 14A Preliminary proxy statement Apr 20, 2026
- DEFA14A Extra proxy material Jun 18, 2025
- DEFA14A Extra proxy material May 1, 2025
- DEF 14A Proxy statement for a shareholder vote May 1, 2025
- PRE 14A Preliminary proxy statement Apr 18, 2025
- DEFA14A Extra proxy material Jun 20, 2024
Ownership 8 of 377
- 4 Insider reported a trade Sep 8, 2026
- 4 Insider reported a trade Aug 26, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jul 22, 2026
- 4 Insider reported a trade Jul 2, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 30, 2026
- 4 Insider reported a trade Jun 5, 2026
Other 8 of 151
Everything here comes from Provectus Biopharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.